Northwestern Mutual Wealth Management
ACTU

Northwestern Mutual Wealth Management’s Actuate Therapeutics ACTU Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio ACTU Stock Details ACTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$86K Buy
31,396
+12,878
+70% +$53.4K ﹤0.01% 2230
2025
Q4 		$113K Sell
18,518
-783
-4% -$5.38K ﹤0.01% 2086
2025
Q3 		$129K Buy
19,301
+783
+4% +$5.68K ﹤0.01% 1959
2025
Q2 		$113K Buy
18,518
+15,393
+493% +$134K ﹤0.01% 1962
2025
Q1 		$21.2K Buy
+3,125
New +$25.1K ﹤0.01% 2489

Other funds holding ACTU

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northwestern Mutual Wealth Management's ACTU Position: Q1 2026 in Review

Northwestern Mutual Wealth Management increased its Actuate Therapeutics (ACTU) stake by 70% in Q1 2026, buying an estimated $53.4K and bringing the position to 31,396 shares worth $86K. The position accounts for ﹤0.01% of the portfolio, ranked #2230.

Northwestern Mutual Wealth Management first reported a position in ACTU in Q1 2025 and has held it in 5 quarters since. The position peaked at $129K in Q3 2025. 61 funds tracked by Wall St. Rank hold ACTU as of Q1 2026.

  • Northwestern Mutual Wealth Management held 31,396 shares of Actuate Therapeutics worth $86K as of Q1 2026.
  • Northwestern Mutual Wealth Management bought 12,878 Actuate Therapeutics shares in Q1 2026, an estimated $53.4K.
  • Actuate Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #2230 holding.
  • Northwestern Mutual Wealth Management first reported a position in Actuate Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • Northwestern Mutual Wealth Management's Actuate Therapeutics position peaked at $129K in Q3 2025.
  • 61 funds tracked by Wall St. Rank held Actuate Therapeutics as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.